Article Information
History
- March 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nawaf Alanazi1,
- Abdulaziz Siyal2,
- Salman Basit3,
- Masood Shammas4,
- Aamer Aleem2,
- Amer Mahmood2,*,
- Sarah Al-Mukhaylid5,6 and
- Zafar Iqbal5,6,7,8,9,*
- 1Department of Pediatrics, King Abdulaziz Hospital, Al-Ahsa, Saudi Arabia
- 2College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
- 3Centre for Genetics and Inherited Diseases, Taiba University, Madinah, Saudi Arabia
- 4Dana Farbar Cancer Institute, University of Harvard, Boston USA
- 5Clinical Laboratory Sciences Program (CLAB), COAMS-A, King Saud Bin Abdulaziz University for Health Sciences/KAIMRC: King Abdulaziz Medical City, Al Ahsa, Saudi Arabia
- 6Genomic Medicine & Oncology/Hematology Group, CoAMS-A, King Saud Bin Abdulaziz University for Health Sciences & King Abdullah International Medical Research Centre (KAIMRC) / SSBMT, King Abdulaziz Medical City, National Guard Health Affairs, Al-Ahsa, Saudi Arabia
- 7Hematology, Oncology & Pharmacogenetic Engineering Sciences (HOPES) Group, Department of Zoology, Univ. of Punjab, Pakistan (King Saud Bin Abdulaziz Univ.), Lahore, Pakistan
- 8Pakistan Society for Molecular and Clinical Hematology, Lahore, Pakistan
- 9Centre for Applied Molecular Biology (CAMB), University of the Punjab, Lahore 54590, Pakistan
- ↵*Corresponding authors Dr. Amer Mahmood and Dr. Zafar Iqbal, ammahmood{at}ksu.edu.sa, Drzafar.medgen1{at}gmail.com ; iqbalz{at}ksau-hs.edu.sa
Posted March 15, 2024.
A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia
